Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

TTempest Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
T

Tempest Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Sep 22, 2026Smith Nancy FredaDirector25,000Stock Option (right to buy)$25KGrant / award
Jun 4, 2026Yee John D.Director25,000Stock Option (right to buy)$38.3KGrant / award
Jun 4, 2026Richey William DrakeDirector25,000Stock Option (right to buy)$38.3KGrant / award
Mar 31, 2026Maestas NicholasChief Financial Officer140,000Employee Stock Option (right to buy)$242.2KGrant / award
Mar 31, 2026Trojanowski JustinCorporate Controller22,000Employee Stock Option (right to buy)$38.1KGrant / award
Mar 24, 2026Angel MatthewCEO and President231,482Series B Warrant (right to buy)$530.1KBuy
Mar 24, 2026Angel MatthewCEO and President231,482Series A Warrant (right to buy)$530.1KBuy
Mar 24, 2026Angel MatthewCEO and President462,964Common Stock$1.1MBuy
Feb 4, 2026Angel MatthewCEO and President269,621Employee Stock Option (right to buy)$733.4KGrant / award
Jan 27, 2026Pellizzari Christine ADirector1,230Stock Option (right to buy)$3.7KGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
$1.00Close · Sep 22, 2026